Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-091622·Hezbay Holdings LLC
Schedule 13D ownership disclosure
MATINAS BIOPHARMA HLDGS INC
COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 576810303
Event date: 2025-09-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hezbay Holdings LLCReported CIK 0002058272
Shares: 253,841.00 · Class: 4.99%
- Ari Kluger
Shares: 253,841.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-091622
- Form type
- SCHEDULE 13D/A
- Filer
- Hezbay Holdings LLC
- CIK
- CIK 2058272
- Filed
- Sep 25, 2025
- Reporting period
- Sep 25, 2025
- Description
- Schedule 13D beneficial ownership